Truvestments Capital’s Opko Health OPK Stock Holding History

Truvestments Capital’s Portfolio OPK Stock Details OPK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-100	Closed	-$166	–	1060
2025 Q1	$166	Buy	+100	New	+$165	﹤0.01%	997

Other funds holding OPK

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Truvestments Capital's OPK Position: Q2 2025 in Review

Truvestments Capital sold out of Opko Health (OPK) in Q2 2025, closing a stake of 100 shares — an estimated $166 sold.

Truvestments Capital first reported a position in OPK in Q1 2025 and held it in 1 quarter. The position peaked at $166 in Q1 2025. 222 funds tracked by Wall St. Rank hold OPK as of Q2 2025.

Truvestments Capital reported no remaining Opko Health position as of Q2 2025 after selling out during the quarter.
Truvestments Capital sold 100 Opko Health shares in Q2 2025, an estimated $166.
Truvestments Capital first reported a position in Opko Health in Q1 2025 and held it in 1 quarter.
Truvestments Capital's Opko Health position peaked at $166 in Q1 2025.
222 funds tracked by Wall St. Rank held Opko Health as of Q2 2025.

Based on Truvestments Capital's 13F filing for Q2 2025, filed 13 Aug 2025.